Sedating ventilated COVID-19 patients with inhalational anesthetic drugs.
作者信息
Orser Beverley A, Wang Dian-Shi, Lu Wei-Yang
机构信息
Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario M5G 1E2, Canada; Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada; Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada.
Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
出版信息
EBioMedicine. 2020 May;55:102770. doi: 10.1016/j.ebiom.2020.102770. Epub 2020 Apr 21.
Abstract
摘要
相似文献
1
Sedating ventilated COVID-19 patients with inhalational anesthetic drugs.使用吸入性麻醉药物对接受机械通气的新冠病毒肺炎患者进行镇静。
EBioMedicine. 2020 May;55:102770. doi: 10.1016/j.ebiom.2020.102770. Epub 2020 Apr 21.
2
Mechanics of Breathing and Gas Exchange in Mechanically Ventilated Patients with COVID-19-associated Respiratory Failure.新型冠状病毒肺炎相关呼吸衰竭机械通气患者的呼吸力学与气体交换
Am J Respir Crit Care Med. 2020 Aug 15;202(4):626-628. doi: 10.1164/rccm.202004-1041LE.
3
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.用于新型冠状病毒肺炎和急性呼吸窘迫综合征的吸入性挥发性镇静剂
Intensive Care Med. 2020 Aug;46(8):1563-1566. doi: 10.1007/s00134-020-06154-8. Epub 2020 Jun 25.
4
Cardiovascular phenotypes in ventilated patients with COVID-19 acute respiratory distress syndrome.患有新型冠状病毒肺炎急性呼吸窘迫综合征的通气患者的心血管表型
Crit Care. 2020 May 18;24(1):236. doi: 10.1186/s13054-020-02958-8.
5
Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?新型冠状病毒肺炎中急性呼吸窘迫综合征的异质性：是否为“典型”？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):618-619. doi: 10.1164/rccm.202004-1106LE.
6
Covid-19, Angiogenesis, and ARDS Endotypes.新型冠状病毒肺炎、血管生成与急性呼吸窘迫综合征的内型
N Engl J Med. 2020 Jul 9;383(2):182-183. doi: 10.1056/NEJMe2018629. Epub 2020 May 21.
7
Are certain drugs associated with enhanced mortality in COVID-19?某些药物是否与新冠病毒疾病（COVID-19）死亡率升高有关？
QJM. 2020 Jul 1;113(7):509-510. doi: 10.1093/qjmed/hcaa103.
8
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?2019冠状病毒病患者急性呼吸窘迫综合征的体外膜肺氧合：我们目前了解多少？
Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24.
9
Inhibiting IL-6 in COVID-19: we are not sure.在新冠肺炎中抑制白细胞介素-6：我们并不确定。
Crit Care. 2020 Jul 27;24(1):463. doi: 10.1186/s13054-020-03177-x.
10
Treatment of COVID-19 by Inhaled NO to Reduce Shunt?吸入一氧化氮治疗新型冠状病毒肺炎以减少分流？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):618. doi: 10.1164/rccm.202004-0940LE.
引用本文的文献
1
Use of Early Ketamine Sedation and Association With Clinical and Cost Outcomes Among Mechanically Ventilated Patients With COVID-19: A Retrospective Cohort Study.COVID-19 机械通气患者早期使用氯胺酮镇静与临床和成本结局的关联：一项回顾性队列研究。
Crit Care Explor. 2024 Jun 21;6(7):e1105. doi: 10.1097/CCE.0000000000001105. eCollection 2024 Jul 1.
2
Sevoflurane sedation in COVID-19 acute respiratory distress syndrome: an observational study with a propensity score matching model.七氟醚用于新型冠状病毒肺炎急性呼吸窘迫综合征的镇静治疗：一项倾向评分匹配模型的观察性研究
Front Med (Lausanne). 2023 Sep 15;10:1267691. doi: 10.3389/fmed.2023.1267691. eCollection 2023.
3
Sedation with Sevoflurane versus Propofol in COVID-19 Patients with Acute Respiratory Distress Syndrome: Results from a Randomized Clinical Trial.七氟醚与丙泊酚用于新型冠状病毒肺炎急性呼吸窘迫综合征患者镇静的随机临床试验结果
J Pers Med. 2023 May 31;13(6):925. doi: 10.3390/jpm13060925.
4
Use of volatile anesthetics for sedation in the ICU during the COVID-19 pandemic: A national survey in France (VOL'ICU 2 study).在 COVID-19 大流行期间 ICU 镇静中使用挥发性麻醉剂：法国的一项全国性调查（VOL'ICU 2 研究）。
PLoS One. 2022 Dec 29;17(12):e0278090. doi: 10.1371/journal.pone.0278090. eCollection 2022.
5
Trends in the Use of Sedative-Hypnotics, Opioids, and Neuromuscular Blockers in Hospitalized Patients During the COVID-19 Pandemic: Observational Retrospective Study.COVID-19大流行期间住院患者使用镇静催眠药、阿片类药物和神经肌肉阻滞剂的趋势：观察性回顾性研究
Drugs Real World Outcomes. 2022 Dec;9(4):629-638. doi: 10.1007/s40801-022-00337-z. Epub 2022 Nov 3.
6
Inhaled Sedation for Invasively Ventilated COVID-19 Patients: A Systematic Review.有创通气的新冠肺炎患者的吸入镇静：一项系统评价
J Clin Med. 2022 Apr 29;11(9):2500. doi: 10.3390/jcm11092500.
7
Extracorporeal membrane oxygenation and inhaled sedation in coronavirus disease 2019-related acute respiratory distress syndrome.体外膜肺氧合与吸入镇静在2019冠状病毒病相关急性呼吸窘迫综合征中的应用
World J Crit Care Med. 2021 Nov 9;10(6):323-333. doi: 10.5492/wjccm.v10.i6.323.
8
Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.重症 COVID-19 患者中异氟烷和丙泊酚镇静的比较——一项回顾性病历审查
J Anesth. 2021 Oct;35(5):625-632. doi: 10.1007/s00540-021-02960-6. Epub 2021 Jun 25.
9
Sedation during mechanical ventilation of COVID-19 patients in intensive care units into operating rooms.重症监护病房中新型冠状病毒肺炎患者机械通气期间的镇静转入手术室。
Braz J Anesthesiol. 2021 Jan-Feb;71(1):91-92. doi: 10.1016/j.bjane.2020.09.013. Epub 2020 Dec 26.
10
Volatile Isoflurane in Critically Ill Coronavirus Disease 2019 Patients-A Case Series and Systematic Review.2019年冠状病毒病危重症患者使用挥发性异氟烷——病例系列与系统评价
Crit Care Explor. 2020 Oct 21;2(10):e0256. doi: 10.1097/CCE.0000000000000256. eCollection 2020 Oct.
本文引用的文献
1
A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA Receptors in the Lung.一种新型口服哮喘药物候选物，通过靶向肺部的 GABA 受体减少平滑肌收缩和炎症。
Mol Pharm. 2018 May 7;15(5):1766-1777. doi: 10.1021/acs.molpharmaceut.7b01013. Epub 2018 Apr 2.
2
Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.七氟醚用于急性呼吸窘迫综合征镇静。一项随机对照初步研究。
Am J Respir Crit Care Med. 2017 Mar 15;195(6):792-800. doi: 10.1164/rccm.201604-0686OC.
3
Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation?挥发性麻醉剂。在重症监护镇静中是否出现了新的玩家？
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1202-12. doi: 10.1164/rccm.201512-2435CP.
4
Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury.麻醉方案对急性肺损伤大鼠模型炎症反应的影响。
Intensive Care Med. 2012 Sep;38(9):1548-55. doi: 10.1007/s00134-012-2610-4. Epub 2012 Jun 19.
Zotero 插件